News
Viking Therapeutics Slumps as Weight-Loss Pill Study Underwhelms
Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage study, marking another weaker-than-expected result for an oral alternative to popular weight-loss injections.
Using GLP-1 drugs for weight loss is considered safe but can come with a loss of lean muscle mass. It’s crucial to do ...
People whose diet contained fewer processed foods lost twice as much weight than people who ate more ultra-processed foods, a ...
The Fox News Lifestyle Newsletter brings you trending stories on family, travel, food, neighbors helping neighbors, pets, ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the ...
Jelly Roll's wife Bunnie XO is poking fun at his major weight loss: "When you have to check and make sure he's still your squish." ...
With the price of Mounjaro set to rise, many are hoping for a replacement and a new drug could be out next year ...
Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback